On October 23, Jinshi Data announced that Zhendong Pharmaceuticals plans to repurchase RMB ordinary shares with its own funds, and the repurchase price will not exceed RMB 6 per share. The total amount of funds for this repurchase is capped at 100 million yuan, with a minimum of 50 million yuan. The estimated number of repurchased shares is approximately 16.67 million shares, accounting for 1.66% of the company’s total share capital.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Zhendong Pharmaceutical: plans to repurchase shares of 50 million yuan to 100 million yuan
On October 23, Jinshi Data announced that Zhendong Pharmaceuticals plans to repurchase RMB ordinary shares with its own funds, and the repurchase price will not exceed RMB 6 per share. The total amount of funds for this repurchase is capped at 100 million yuan, with a minimum of 50 million yuan. The estimated number of repurchased shares is approximately 16.67 million shares, accounting for 1.66% of the company’s total share capital.